Cargando…
Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum
Aberrant epigenetic modifications are an early event in carcinogenesis, with the epigenetic landscape continuing to change during tumor progression and metastasis—these observations suggest that specific epigenetic modifications could be used as diagnostic and prognostic biomarkers for many cancer t...
Autores principales: | Thomas, Margaret L., Marcato, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923356/ https://www.ncbi.nlm.nih.gov/pubmed/29614786 http://dx.doi.org/10.3390/cancers10040101 |
Ejemplares similares
-
Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
por: Coyle, Krysta Mila, et al.
Publicado: (2017) -
Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells
por: Dahn, Margaret L., et al.
Publicado: (2020) -
The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023) -
THE MANY VOICES OF CARE PARTNERS ACROSS THE CONTINUUM OF CARE
por: Fox, Aimee, et al.
Publicado: (2022) -
Virtual Care Across the Neonatal Intensive Care Continuum
por: Desai, Purnahamsi, et al.
Publicado: (2023)